NCT01039207 2017-09-07Rilotumumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerGOG FoundationPhase 2 Completed31 enrolled 12 charts
NCT01113398 2015-12-10AMG 102 and Avastin for Recurrent Malignant GliomaDuke UniversityPhase 2 Completed36 enrolled 9 charts
NCT01105390 2013-08-02AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural MesotheliomaNational Cancer Institute (NCI)Phase 2 Withdrawn